Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench during President Donald Trump's first term. U.S. District Judge Matthew Kacsmaryk ruled that Missouri,
Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.
Three Republican-led states will be allowed to move forward with a lawsuit to restrict access to mifepristone, a Texas federal judge ruled Thursday, months after the Supreme Court rejected an
The new Trump administration could put a stop to pending litigation on the abortion pill mifepristone and other federal abortion policies through changes at the Department of Health and Human Services, according to a top anti-abortion lawyer involved in several pending cases.
The federal judge who paved a path for abortion drug clearance to reach the Supreme Court has allowed red states to revive the legal battle against mifepristone. | U.S. District Judge Matthew Kacsmaryk ruled Thursday that Idaho,
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.
Idaho, Kansas and Missouri want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven weeks of
A Texas judge has allowed Idaho, Kansas, and Missouri to challenge federal rules on the abortion drug mifepristone. The states want stricter regulations, citing conflict with state abortion laws. The case continues despite a prior Supreme Court decision maintaining access to the drug.
After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.
Anti-abortion groups are executing a multi-pronged state lobbying campaign to limit access to abortion medication as question marks surround ongoing federal litigation and the Trump administration’s approach to the issue.
A Texas federal judge Thursday ruled Idaho, Kansas, and Missouri can join a case challenging access to the abortion pill. Trump-appointed Judge Matthew Kacsmaryk allowed the states to pursue legal action in Texas that seeks to prohibit the Food and Drug Administration (FDA) from allowing online prescriptions for Mifepristone over concerns that it could “undermine state abortion laws and frustrate state law enforcement,
(CNN) — Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court ...